CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Stifel 2016 Healthcare Conference
November 08, 2016 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced it will...
CidaraLogo (1).jpg
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
November 02, 2016 07:30 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
October 13, 2016 09:20 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing...
CidaraLogo (1).jpg
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
October 07, 2016 09:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
September 20, 2016 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Reports Second Quarter 2016 Financial Results and Provides Corporate Update
August 11, 2016 16:12 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Cantor Fitzgerald Annual Healthcare Conference
July 06, 2016 07:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, July 06, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics Expands Management Team
July 05, 2016 07:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, July 05, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at the Jefferies 2016 Healthcare Conference
June 02, 2016 08:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, June 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
CidaraLogo (1).jpg
Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 12, 2016 17:12 ET | Cidara Therapeutics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...